Subhasree Balakrishnan

489 citations
3 papers · 299 indexed · h-index 3
Topics
PI3K/AKT/mTOR signaling in cancer (2 papers)Cancer Cells and Metastasis (2 papers)Angiogenesis and VEGF in Cancer (1 paper)
Partner nations
United StatesCanada

In The Last Decade

Subhasree Balakrishnan

3 papers receiving 297 citations

Peers

Subhasree Balakrishnan
Comparison fields: 5 of 54
  • Molecular Biology 211
  • Oncology 88
  • Cancer Research 79
  • Pulmonary and Respiratory Medicine 76
  • Immunology 32
Replace Liran Zhou with:
Liran Zhou United States
Katja Helenius Finland
Verónica Moncho-Amor Spain
Sijana H. Dzinic United States
Masashige Tendo Japan
Franziska Niehr Germany
Jang-Hyun Choi South Korea
Ielizaveta Gorodetska Germany
Zining Jin China
Nilesh Gardi India
Subhasree Balakrishnan relative to Liran Zhou United States Liran Zhou's profile →
Citations per field
00.5×1.5×1.8×
Liran Zhou · 1×
Citations per year

Countries citing papers authored by Subhasree Balakrishnan

Since Specialization
Citations

This map shows the geographic impact of Subhasree Balakrishnan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Subhasree Balakrishnan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Subhasree Balakrishnan more than expected).

Fields of papers citing papers by Subhasree Balakrishnan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Subhasree Balakrishnan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Subhasree Balakrishnan. The network helps show where Subhasree Balakrishnan may publish in the future.

Co-authorship network of co-authors of Subhasree Balakrishnan

This figure shows the co-authorship network connecting the top 25 collaborators of Subhasree Balakrishnan. A scholar is included among the top collaborators of Subhasree Balakrishnan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Subhasree Balakrishnan. Subhasree Balakrishnan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

About Subhasree Balakrishnan

Subhasree Balakrishnan is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 3 papers that have together received 299 indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (2 papers), Cancer Cells and Metastasis (2 papers) and Angiogenesis and VEGF in Cancer (1 paper). The work is most often cited by research in Cancer Research (79 citations), Oncology (88 citations) and Molecular Biology (211 citations). Subhasree Balakrishnan has collaborated with scholars based in United States and Canada. Frequent co-authors include Michael C. Ostrowski, Gina M. Sizemore, Jason R. Pitarresi, Julie A. Wallace, Gustavo Leone, Lianbo Yu, Raleigh D. Kladney, S. A. Fernandez, Carmen Z. Cantemir-Stone and Sudarshana M. Sharma. Their work appears in journals such as Nature reviews. Cancer, PLoS ONE and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026